pharma news, views and analysis

in Market Access
Realising the biotech promise: addressing the path to market
September 6, 2018 Share
X
Realising the biotech promise: addressing the path to market
https://pharmaphorum.com/market-access-2/addressing-the-path-to-market/
in Debates & Insight
Digital therapeutics and healthcare innovation
September 4, 2018 Share
X
Digital therapeutics and healthcare innovation
https://pharmaphorum.com/debates-insight-digital/digital-therapeutics-and-healthcare-innovation/
in News
AZ grabs EU approval for Imfinzi in advanced lung cancer
September 25, 2018 Share
X
AZ grabs EU approval for Imfinzi in advanced lung cancer
https://pharmaphorum.com/news/az-grabs-eu-approval-for-imfinzi-in-advanced-lung-cancer/
in News
Patients call for end to CF drug price row at key meeting
September 25, 2018 Share
X
Patients call for end to CF drug price row at key meeting
https://pharmaphorum.com/news/patients-call-for-cf-drug-price-agreement-ahead-of-meeting/
in Views & Analysis
Chinese pharma market primed for growth after sweeping reforms
September 25, 2018 Share
X
Chinese pharma market primed for growth after sweeping reforms
https://pharmaphorum.com/r-d/views-analysis-r-d/chinese-pharma-market/
in Views & Analysis
A global outlook: government affairs and policy
September 24, 2018 Share
X
A global outlook: government affairs and policy
https://pharmaphorum.com/views-analysis-patients/a-global-outlook-government-affairs-and-policy/

Latest News

Novartis to cut 2,200 jobs in Switzerland to boost profits

Novartis has announced that it will cut 2,200 jobs in Switzerland to boost its profitability. The company told

Novartis to cut 2,200 jobs in Switzerland to boost profits

https://pharmaphorum.com/news/novartis-to-cut-2200-jobs-in-switzerland-to-boost-profits/

Gilead launches generics of own hepatitis C drugs in US to cut health costs

Gilead is to launch cheaper generic versions of its hepatitis C drugs in the US, responding to calls

Gilead launches generics of own hepatitis C drugs in US to cut health costs

https://pharmaphorum.com/news/gilead-launches-generics-of-own-hepatitis-c-drugs-in-us-to-cut-health-costs/

Merck and Pfizer trial cancer combination with Australia’s Immutep

Australian biotech Immutep has begun a clinical trial partnership with Germany’s Merck KGaA and Pfizer to develop a

Merck and Pfizer trial cancer combination with Australia’s Immutep

https://pharmaphorum.com/news/merck-and-pfizer-trial-cancer-combination-with-australias-immutep/

See all

Views & analysis

Digital news round-up: AZ taps into China with robots, and ECG app wars

Richard Staines presents his weekly round-up of the latest digital health stories

Digital news round-up: AZ taps into China with robots, and ECG app wars

https://pharmaphorum.com/views-analysis-digital/astrazeneca-taps-into-china-with-robots-and-ecg-app-wars/

Raising awareness about rare diseases

A family tragedy has prompted Kay Parkinson, founder of the rare disease charity Alstrom Syndrome UK, to create

Raising awareness about rare diseases

https://pharmaphorum.com/views-analysis-patients/awareness-rare-diseases/

How people power is building patient-centric pharma

While everyone is agreed on the importance of patient-centric pharma, just one fifth of industry insiders said they

How people power is building patient-centric pharma

https://pharmaphorum.com/views-analysis-patients/how-people-power-is-building-patient-centric-pharma/

See all

Deep Dive Magazine

CAR-Ts – a new weapon in the fight against cancer

CAR-T – or Chimeric Antigen Receptor T-cell therapies herald a new wave of therapies in cancer. CAR-T therapies

CAR-Ts – a new weapon in the fight against cancer

https://pharmaphorum.com/views-and-analysis/car-ts-a-new-weapon-in-the-fight-against-cancer/

How to achieve digital success in pharma’s communications

Demystifying what digital means, empowering people to ‘think digitally’ and acting with confidence are game changing factors for

How to achieve digital success in pharma’s communications

https://pharmaphorum.com/views-analysis-digital/achieve-digital-success-pharma/

Future-proofing pharma with a multichannel approach to sales and marketing

Deploying a multichannel approach to marketing, backed by the use of advanced analytics, could help pharma evolve and

Future-proofing pharma with a multichannel approach to sales and marketing

https://pharmaphorum.com/views-analysis-sales-marketing/multichannel-marketing-sales-pharma/

See all

Webinars

10/12/2018

Digital therapeutics and healthcare innovation

https://pharmaphorum.com/debates-insight-digital/digital-therapeutics-and-healthcare-innovation/

How to make digital work in medtech

https://pharmaphorum.com/webinars/webinars-on-demand/make-digital-work-medtech/

Engaging with HCPS: what do HCPs want from medical meetings?

https://pharmaphorum.com/webinars/webinars-on-demand/engaging-with-hcps-what-do-hcps-want-from-medical-meetings/

See all

White papers

The changing face of pharmaceutical launches

The industry has experienced a sustained period of change since its blockbuster heyday in the 1990s and continues

The changing face of pharmaceutical launches

https://pharmaphorum.com/market-access-2/digital-transforming-pharmaceutical-launches/

Remote HCP engagement – still a struggle for life science companies

Life science companies are failing to achieve their full digital potential, particularly when it comes to the use

Remote HCP engagement – still a struggle for life science companies

https://pharmaphorum.com/white-papers/remote-hcps-engagement-life-science/

Medical meetings and what HCPs want

The healthcare professional (HCP) meeting landscape is evolving, but even as it adjusts to the demands of the

Medical meetings and what HCPs want

https://pharmaphorum.com/whitepapers/medical-meetings-and-what-hcps-want/

See all

Video

Raising the bar in liver cancer therapy

https://pharmaphorum.com/oncology/insights-oncology/raising-bar-liver-cancer-therapy/

Eisai’s EMEA CEO Gary Hendler on why quality of life is key to Lenvima’s success

https://pharmaphorum.com/oncology/insights-oncology/eisais-emea-ceo-gary-hendler-lenvimas-success/

Part three: Oncology shaping the future of personalised healthcare

https://pharmaphorum.com/video/part-three-oncology-shaping-future-personalised-healthcare/

See all

Partner content

Press releases

Immuno-Oncology 2018 News: MHRA Interview and New Speaker ImmuneBiotech AB Announced

https://pharmaphorum.com/partner-content/immuno-oncology-2018-news-mhra-interview-and-new-speaker-immunebiotech-ab-announced/

Only 4 Weeks Until Orphan Drugs & Rare Diseases 2018

https://pharmaphorum.com/partner-content/only-4-weeks-until-orphan-drugs-rare-diseases-2018/

Antibiotic Class Emerges through Digestive Enzyme

https://pharmaphorum.com/partner-content/antibiotic-class-emerges-through-digestive-enzyme-2/

Achieving Controlled Nucleation During Aseptic Lyophilization

https://pharmaphorum.com/partner-content/achieving-controlled-nucleation-during-aseptic-lyophilization/

See all

Appointments

Carina Schey, University of Groningen, Orphan Drugs & Rare Diseases Chair Invitation

https://pharmaphorum.com/partner-content/carina-schey-university-of-groningen-orphan-drugs-rare-diseases-chair-invitation/

Corporate Communications chief of Astellas, Jo Taylor moves to Cello Health Communications

https://pharmaphorum.com/partner-content/corporate-communications-chief-of-astellas-jo-taylor-moves-to-cello-health-communications/

See all

Search

Advanced Search

Trending

Press releases

Appointments